129.45000 EUR
0.2
0.15%
Last update Dec 16, 8:10 AM CET
Main market
Day range
129.45000
129.45000
Previous close
129.25
Open
129.45000
Access this stock data via API
Subscribe
Neurocrine Biosciences Inc.
129.45
0.20
0.15%

Statistics

Valuation metrics
Market cap
0
Enterprise value
0
Trailing P/E (ttm)
37.01
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
0
Enterprise Value/EBITDA
0
Overview
Shares outstanding
99.70M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
9
Average volume (90 days)
3
Price summary
52-Week low
77.08
52-Week high
147
52-Week change
-2.86 -3.7%
Beta
50-Day moving average
123.99
200-Day moving average
111.32
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
98.56%
Operating margin
26.01%
Operational effectiveness
Return on assets
9.18%
Return on equity
13.18%
Income statement
Revenue (ttm)
2.01B
Revenue per share (ttm)
23.46
Quarterly revenue growth (yoy)
15.62%
Gross profit (ttm)
1.98B
EBITDA
428.09M
Net income to common (ttm)
290.87M
Diluted EPS (ttm)
3.29
Quarterly earnings growth (yoy)
25.97%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
0
Total Debt/Equity (mrq)
0
Current ratio (mrq)
338.31%
Book value per share (mrq)
Cash flow
Cash flow statement
473.42M
Levered free cash flow (LFCF)
290.87M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 51 minutes

15:08
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).